Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimebon in Huntington's Disease (DIMOND)
NCT00497159Phase 2Completed
- Sponsor
- Medivation
- Start
- Jul 2007
- Primary completion
- Jun 2008
- Modality
- Classical Binding Small Molecules, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of latrepirdine in Huntington's disease (HD), sponsored by Medivation. Started Jul 2007; status: completed.
02
Drugs
latrepirdine
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT00497159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00497159.